We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
Cap. Flow
-$256M
Cap. Flow %
-0.25%
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$35.4M
2
P
Everpure Inc
P
+$21M
3
NVDA icon
NVIDIA
NVDA
+$20.7M
4
AMH icon
American Homes 4 Rent
AMH
+$19.3M
5
DAY
Dayforce
DAY
+$19M

Sector Composition

Rank Sector Weight
1 Technology 28.42%
2 Financials 13.09%
3 Healthcare 11.94%
4 Consumer Discretionary 10.95%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ULCC icon
2101
Frontier Group Holdings
ULCC
$1.56B
$1.27M ﹤0.01%
156,527
-170
-0.1% -$1.1K
NFBK
2102
DELISTED
Northfield Bancorp
NFBK
$1.27M ﹤0.01%
130,534
-4,101
-3% -$45K
ARCT icon
2103
Arcturus Therapeutics
ARCT
$200M
$1.27M ﹤0.01%
37,568
+1,409
+4% +$49.9K
HE icon
2104
Hawaiian Electric Industries
HE
$2.02B
$1.27M ﹤0.01%
112,434
-17,740
-14% -$225K
TU icon
2105
Telus
TU
$15.1B
$1.26M ﹤0.01%
78,991
-418
-0.5% -$7.31K
EMBJ
2106
Embraer S.A. ADS
EMBJ
$13.1B
$1.26M ﹤0.01%
47,432
-153
-0.3% -$3.04K
LBAI
2107
DELISTED
Lakeland Bancorp Inc
LBAI
$1.26M ﹤0.01%
104,081
+398
+0.4% +$5.11K
DOLE icon
2108
Dole
DOLE
$1.24B
$1.24M ﹤0.01%
104,179
+2,291
+2% +$26.6K
ARQT icon
2109
Arcutis Biotherapeutics
ARQT
$3.26B
$1.24M ﹤0.01%
125,333
+18,402
+17% +$137K
BBSI icon
2110
Barrett Business Services
BBSI
$783M
$1.24M ﹤0.01%
39,120
+832
+2% +$24.1K
BASE
2111
DELISTED
Couchbase
BASE
$1.23M ﹤0.01%
46,837
+1,460
+3% +$38K
AMRX icon
2112
Amneal Pharmaceuticals
AMRX
$5.71B
$1.23M ﹤0.01%
202,931
-9,860
-5% -$55.6K
RELX icon
2113
RELX
RELX
$62.1B
$1.23M ﹤0.01%
28,329
+2,846
+11% +$120K
RVLV icon
2114
Revolve Group
RVLV
$1.73B
$1.23M ﹤0.01%
57,890
+1,255
+2% +$22K
KT icon
2115
KT
KT
$8.72B
$1.22M ﹤0.01%
87,351
+193
+0.2% +$2.66K
MDY icon
2116
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$1.22M ﹤0.01%
2,200
-10,300
-82% -$5.34M
RY icon
2117
Royal Bank of Canada
RY
$293B
$1.22M ﹤0.01%
12,108
+46
+0.4% +$4.54K
PLRX icon
2118
Pliant Therapeutics
PLRX
$64.4M
$1.22M ﹤0.01%
81,826
+1,212
+2% +$20K
ATRO icon
2119
Astronics
ATRO
$3.72B
$1.22M ﹤0.01%
76,608
-6,157
-7% -$91.6K
EVRI
2120
DELISTED
Everi Holdings
EVRI
$1.21M ﹤0.01%
120,651
-2,836
-2% -$29.3K
KNSA icon
2121
Kiniksa Pharmaceuticals
KNSA
$5.97B
$1.21M ﹤0.01%
61,431
+494
+0.8% +$9.65K
BF
2122
DELISTED
BASF AKTIENGESELLT ADS(RP1 ORD
BF
$1.21M ﹤0.01%
84,795
+6,030
+8% +$86.2K
HIT
2123
DELISTED
HITACHI LTD ADR (10COM)NEW
HIT
$1.21M ﹤0.01%
6,634
+625
+10% +$114K
FOR icon
2124
Forestar Group
FOR
$1.46B
$1.2M ﹤0.01%
29,912
-139
-0.5% -$4.72K
JOUT icon
2125
Johnson Outdoors
JOUT
$501M
$1.2M ﹤0.01%
25,978
-10,968
-30% -$504K

Similar funds

RhumbLine Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
  • RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
  • RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
  • RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
  • RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
  • RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
  • RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.